We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOKM.U
14901
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
-152,064
Closed -$1.53M
CNCE
14902
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-10,777
Closed -$37.8K
CNCE
14903
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-13,100
Closed -$55K
CAJ
14904
PUT
DELISTED
Canon, Inc.
CAJ
-11,500
Closed -$260K
LHDX
14905
PUT
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-42,800
Closed -$284K
OIIM
14906
DELISTED
02Micro International
OIIM
-24,142
Closed -$175K
IBER.U
14907
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
-227,788
Closed -$2.29M
ANAC.U
14908
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
-404,661
Closed -$4.05M
FTAA
14909
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
-450,000
Closed -$4.43M
FTAAU
14910
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
-100,000
Closed -$1.02M
FTAAW
14911
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
-112,500
Closed -$169K
NVSAU
14912
DELISTED
New Vista Acquisition Corp Unit
NVSAU
-587,500
Closed -$5.89M
SCOBU
14913
DELISTED
ScION Tech Growth II Units
SCOBU
-665,575
Closed -$6.69M
PFDRU
14914
DELISTED
Pathfinder Acquisition Corporation Unit
PFDRU
-353,916
Closed -$3.52M
HZN
14915
DELISTED
Horizon Global Corporation
HZN
-16,358
Closed -$139K
QUMU
14916
CALL
DELISTED
Qumu Corp.
QUMU
-40,200
Closed -$116K
AHPI
14917
DELISTED
Allied Healthcare Products
AHPI
-19,263
Closed -$80K
CPARU
14918
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
-874,416
Closed -$8.78M
QED
14919
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
-34,185
Closed -$817K
DNZ.U
14920
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
-583,350
Closed -$5.8M
SVFAW
14921
DELISTED
SVF Investment Corp. Warrant
SVFAW
-21,769
Closed -$33K
JCICU
14922
DELISTED
Jack Creek Investment Corp. Units
JCICU
-507,339
Closed -$5.1M
TZPSU
14923
DELISTED
TZP Strategies Acquisition Corp. Unit
TZPSU
-830,027
Closed -$8.28M
AEACU
14924
DELISTED
Authentic Equity Acquisition Corp. Unit
AEACU
-298,297
Closed -$3.02M
AYLA
14925
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
-10,457
Closed -$107K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.